Getting More High Cardiovascular Disease Risk Patients to Goal: Simulations to Improve Real Outcomes
Release Date: October 17, 2011
Expiration Date: October 18, 2013
Expiration Date: October 18, 2013
Accredited
for:
·
Physicians
·
Physician
assistants
·
Nurses
·
Nurse
practitioners
·
Dialysis
technicians
·
Dietitians
·
Pharmacists
Overview
Chronic kidney disease (CKD) is
now widely accepted as an independent risk factor for cardiovascular
disease (CVD), with more patients dying from CVD than from end-stage
renal disease. Cardiovascular risk increases as kidney function
declines, but in the predialysis stages of CKD, risk factor
intervention has been shown to effectively reduce cardiovascular events
and mortality. This CME/CE activity will explore cardiovascular
prevention strategies in patients with stages 1–4 CKD and,
through a dynamic, integrated inter-professional learning approach,
help bridge identified gaps in clinical competency and in the
performance of healthcare providers and healthcare teams.
Learning
Objectives
After completing this educational
activity, you will be able to:
·
Review recommended laboratory measures and other
assessments, with respective targets related to cardiovascular risk, to
aid in assessing and managing CVD risk in high-risk patient populations
to get them to goal
·
Integrate evidence-based guidelines to reduce CVD risk in
high-risk patients to help prevent or minimize adverse long term
outcomes
·
Outline a collaborative inter-professional approach to
better manage CVD risk in high-risk patients and foster best practices
in the delivery of care
Method of
Participation
This CME/CE activity is
available as a dynamic web-based, computer-guided experience that
allows learners to assess the needs of three virtual patients similar
to challenging patients whom they see in practice – people with
multiple risk factors and disease states that pose increased CVD risk.
A complete picture of each “virtual patient” will be
unveiled as the clinician reads the patient record, asks questions, and
elicits findings from laboratory data and physical exams. Once the
learners feel confident about the information, they will be able to
develop a clinical action plan that addresses individual virtual
patient needs, including those for collaborative inter-professional
care. Upon submission of the clinical action plan, learners will be
able to compare their clinical action plans against an evidence-based
“best practice” plan outlined in advance by clinical
experts. To receive a certificate of completion, participants will be
required to complete, at a minimum, one virtual patient experience,
including a post-test and program evaluation. The estimated time for
completion is 1.5 hour. To receive AMA
PRA Category 1 Credits ™, participants must receive a
minimum score of 70% on the post-test.
Faculty
Carol M. Mason,
ARNP, CLS, FAHA,FNLA, FPCNA
President, Accreditation Council for Clinical Lipidology
Trinity, FL
President, Accreditation Council for Clinical Lipidology
Trinity, FL
Carl Orringer,
MD, FACC
Associate Professor of Medicine
Case Western Reserve University
School of Medicine
Cleveland, OH
Associate Professor of Medicine
Case Western Reserve University
School of Medicine
Cleveland, OH
C.
Venkata S. Ram, MD, FACC, MACP
Director, Texas Blood Pressure Institute
Clinical Research Institute of Dallas Nephrology Associates
Dallas, TX
Director, Texas Blood Pressure Institute
Clinical Research Institute of Dallas Nephrology Associates
Dallas, TX
No comments:
Post a Comment